{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T05:44:49Z","timestamp":1783403089125,"version":"3.54.6"},"reference-count":61,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"31","license":[{"start":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T00:00:00Z","timestamp":1722556800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,8,2]]},"abstract":"<jats:p>Xianlinggubao formula (XLGB), is a traditional Chinese compound Medicine that has been extensively used in osteoarthritis and aseptic osteonecrosis, but its curative effect on diabetic osteoporosis (DOP) and its pharmacological mechanisms remains not clear. The aim of the present study was to investigate the possible mechanism of drug repurposing of XLGB in DOP therapy. We acquired XLGB active compounds from the traditional Chinese medicine systems pharmacology and traditional Chinese medicines integrated databases and discovered potential targets for these compounds by conducting target fishing using the traditional Chinese medicine systems pharmacology and Swiss Target Prediction databases. Gene Cards and Online Mendelian Inheritance in Man<jats:sup>\u00ae<\/jats:sup> database were used to identify the DOP targets. Overlapping related targets between XLGB and DOP was selected to build a protein\u2013protein interaction network. Next, the Metascape database was utilized to enrich the Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathways. In addition, Auto-Dock Vina software was used to verify drug and target binding. In total, 48 hub targets were obtained as the candidate targets responsible for DOP therapy. The anti-DOP effect mediated by XLGB was primarily centralized on the advanced glycation end products (AGEs)-receptor for AGE signaling pathway in diabetic complications and osteoclast differentiation. In addition, AKT serine\/threonine kinase 1, tumor necrosis factor, Interleukin-6, vascular endothelial growth factor A and peroxisome proliferator activated receptor gamma, which were considered as potential therapeutic targets. Furthermore, molecular docking results confirm the credibility of the predicted therapeutic targets. This study elucidates that XLGB may through regulating AGEs formation and osteoclast differentiation as well as angiogenesis and adipogenesis against DOP. And this study provides new promising points to find the exact regulatory mechanisms of XLGB mediated anti-DOP effect.<\/jats:p>","DOI":"10.1097\/md.0000000000039138","type":"journal-article","created":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T17:23:13Z","timestamp":1722619393000},"page":"e39138","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Exploring the pharmacological mechanism of Xianlingubao against diabetic osteoporosis based on network pharmacology and molecular docking: An observational study"],"prefix":"10.1097","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0454-3478","authenticated-orcid":false,"given":"Huili","family":"Yan","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory, Changzhi People\u2019s Hospital, Changzhi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongying","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Changzhi People\u2019s Hospital, Changzhi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongwen","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabology, The Third Affiliated Hospital of Shandong First Medical University, Jinan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250503","doi-asserted-by":"crossref","first-page":"1052592","DOI":"10.3389\/fendo.2022.1052592","article-title":"A narrative review of diabetic bone disease: characteristics, pathogenesis, and treatment.","volume":"13","author":"Wu","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R2-20250503","doi-asserted-by":"crossref","first-page":"294","DOI":"10.5114\/reum\/170048","article-title":"Osteoporosis and diabetes \u2013 possible links and diagnostic difficulties.","volume":"61","author":"Tomasiuk","year":"2023","journal-title":"Reumatologia"},{"key":"R3-20250503","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s12902-022-01103-6","article-title":"Metformin activates Wnt\/\u03b2-catenin for the treatment of diabetic osteoporosis.","volume":"22","author":"Huang","year":"2022","journal-title":"BMC Endocr Disord"},{"key":"R4-20250503","doi-asserted-by":"crossref","first-page":"9872243","DOI":"10.1155\/2022\/9872243","article-title":"ATF3 regulates osteogenic function by mediating osteoblast ferroptosis in Type 2 Diabetic Osteoporosis.","volume":"2022","author":"Zhao","year":"2022","journal-title":"Dis Markers"},{"key":"R5-20250503","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1080\/14712598.2019.1618266","article-title":"An update on therapies for the treatment of diabetes-induced osteoporosis.","volume":"19","author":"Mohsin","year":"2019","journal-title":"Expert Opin Biol Ther"},{"key":"R6-20250503","doi-asserted-by":"crossref","first-page":"291","DOI":"10.36290\/vnl.2021.076","article-title":"Osteoporosis in diabetes mellitus patients.","volume":"67","author":"Jackuliak","year":"2021","journal-title":"Vnitr Lek"},{"key":"R7-20250503","doi-asserted-by":"crossref","first-page":"981487","DOI":"10.3389\/fendo.2022.981487","article-title":"The pathophysiology of osteoporosis in obesity and type 2 diabetes in aging women and men: the mechanisms and roles of increased bone marrow adiposity.","volume":"13","author":"Ali","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R8-20250503","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s11657-021-01030-4","article-title":"Anemia is related to osteoporosis in Chinese type 2 diabetic patients.","volume":"16","author":"Cui","year":"2021","journal-title":"Arch Osteoporos"},{"key":"R9-20250503","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1186\/s12967-024-05191-x","article-title":"Type 2 diabetic mellitus related osteoporosis: focusing on ferroptosis.","volume":"22","author":"Chen","year":"2024","journal-title":"J Transl Med"},{"key":"R10-20250503","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s12906-020-03007-1","article-title":"Deciphering the underlying mechanism of Xianlinggubao capsule against osteoporosis by network pharmacology.","volume":"20","author":"Bao","year":"2020","journal-title":"BMC Complement Med Ther"},{"key":"R11-20250503","doi-asserted-by":"crossref","first-page":"106182","DOI":"10.1016\/j.jsbmb.2022.106182","article-title":"Inhibition of estrogen sulfation by Xian-Ling-Gu-Bao capsule.","volume":"225","author":"He","year":"2023","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R12-20250503","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11626-020-00530-w","article-title":"Xian-Ling-Gu-Bao protects osteoporosis through promoting osteoblast differentiation by targeting miR-100-5p\/KDM6B\/RUNX2 axis.","volume":"57","author":"Ai","year":"2021","journal-title":"In Vitro Cell Dev Biol Anim"},{"key":"R13-20250503","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/s00198-011-1577-2","article-title":"The first multicenter and randomized clinical trial of herbal Fufang for treatment of postmenopausal osteoporosis.","volume":"23","author":"Zhu","year":"2012","journal-title":"Osteoporos Int"},{"key":"R14-20250503","first-page":"359","article-title":"Effect of Xianling Gubao capsules on bone mineral density in osteoporosis patients.","volume":"31","author":"Wu","year":"2017","journal-title":"J Biol Regul Homeost Agents"},{"key":"R15-20250503","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/nbt1007-1110","article-title":"Network pharmacology.","volume":"25","author":"Hopkins","year":"2007","journal-title":"Nat Biotechnol"},{"key":"R16-20250503","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S1875-5364(13)60037-0","article-title":"Traditional Chinese medicine network pharmacology: theory, methodology and application.","volume":"11","author":"Li","year":"2013","journal-title":"Chin J Natural Med"},{"key":"R17-20250503","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1758-2946-6-13","article-title":"TCMSP: a database of systems pharmacology for drug discovery from herbal medicines.","volume":"6","author":"Ru","year":"2014","journal-title":"J Cheminform"},{"key":"R18-20250503","doi-asserted-by":"crossref","first-page":"D1089","DOI":"10.1093\/nar\/gks1100","article-title":"TCMID: traditional Chinese medicine integrative database for herb molecular mechanism analysis.","volume":"41","author":"Xue","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"R19-20250503","doi-asserted-by":"crossref","first-page":"D158","DOI":"10.1093\/nar\/gkw1099","article-title":"The UniProt Consortium. UniProt: the universal protein knowledgebase.","volume":"45","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"R20-20250503","doi-asserted-by":"crossref","first-page":"W357","DOI":"10.1093\/nar\/gkz382","article-title":"SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules.","volume":"47","author":"Daina","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"R21-20250503","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/bioinformatics\/14.8.656","article-title":"GeneCards: a novel functional genomics compendium with automated data mining and query reformulation support.","volume":"14","author":"Rebhan","year":"1998","journal-title":"Bioinformatics"},{"key":"R22-20250503","doi-asserted-by":"crossref","first-page":"D514","DOI":"10.1093\/nar\/gki033","article-title":"Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders.","volume":"33","author":"Hamosh","year":"2005","journal-title":"Nucleic Acids Res"},{"key":"R23-20250503","doi-asserted-by":"crossref","first-page":"D36","DOI":"10.1093\/nar\/gku1055","article-title":"Gene: a gene-centered information resource at NCBI.","volume":"43","author":"Brown","year":"2015","journal-title":"Nucleic Acids Res"},{"issue":"Suppl 4","key":"R24-20250503","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1186\/1752-0509-8-S4-S11","article-title":"cytoHubba: identifying hub objects and sub-networks from complex interactome.","volume":"8","author":"Chin","year":"2014","journal-title":"BMC Syst Biol"},{"key":"R25-20250503","doi-asserted-by":"crossref","first-page":"D362","DOI":"10.1093\/nar\/gkw937","article-title":"The STRING database in 2017: quality-controlled protein\u2013protein association networks, made broadly accessible.","volume":"45","author":"Szklarczyk","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"R26-20250503","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks.","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res"},{"key":"R27-20250503","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","article-title":"Metascape provides a biologist-oriented resource for the analysis of systems-level datasets.","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat Commun"},{"key":"R28-20250503","doi-asserted-by":"crossref","first-page":"D344","DOI":"10.1093\/nar\/gkz853","article-title":"PDBe-KB: a community-driven resource for structural and functional annotations.","volume":"48","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"R29-20250503","first-page":"443","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility.","volume":"48","author":"Morris","year":"2009","journal-title":"J Comput Chem"},{"key":"R30-20250503","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading.","volume":"31","author":"Trott","year":"2009","journal-title":"J Comput Chem"},{"key":"R31-20250503","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1589\/jpts.27.179","article-title":"Bone mineral density evaluation of patients with type 2 diabetes mellitus.","volume":"27","author":"Adil","year":"2015","journal-title":"J Phys Ther Sci"},{"key":"R32-20250503","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ecl.2016.09.010","article-title":"Diabetes and bone disease.","volume":"46","author":"Schacter","year":"2017","journal-title":"Endocrinol Metab Clin North Am"},{"key":"R33-20250503","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/s41574-023-00866-9","article-title":"Long-term and sequential treatment for osteoporosis.","volume":"19","author":"Foessl","year":"2023","journal-title":"Nat Rev Endocrinol"},{"key":"R34-20250503","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1177\/0004563218759371","article-title":"The bone remodelling cycle.","volume":"55","author":"Kenkre","year":"2018","journal-title":"Ann Clin Biochem"},{"key":"R35-20250503","doi-asserted-by":"crossref","first-page":"e12866","DOI":"10.1111\/cpr.12866","article-title":"Morroniside attenuates high glucose-induced BMSC dysfunction by regulating the Glo1\/AGE\/RAGE axis.","volume":"53","author":"Sun","year":"2020","journal-title":"Cell Prolif"},{"key":"R36-20250503","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.1039\/C9BM00184K","article-title":"Glycated collagen \u2013 a 3D matrix system to study pathological cell behavior.","volume":"7","author":"Dandia","year":"2019","journal-title":"Biomater Sci"},{"key":"R37-20250503","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.3390\/biom10071052","article-title":"Coumarin ameliorates impaired bone turnover by inhibiting the formation of advanced glycation end products in diabetic osteoblasts and osteoclasts.","volume":"10","author":"Lee","year":"2020","journal-title":"Biomolecules"},{"key":"R38-20250503","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.3390\/molecules25235591","article-title":"The Development of Maillard Reaction, and Advanced Glycation End Product (AGE)-Receptor for AGE (RAGE) signaling inhibitors as novel therapeutic strategies for patients with AGE-Related Diseases.","volume":"25","author":"Shen","year":"2020","journal-title":"Molecules"},{"key":"R39-20250503","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s00774-013-0514-1","article-title":"IL-6 negatively regulates osteoblast differentiation through the SHP2\/MEK2 and SHP2\/Akt2 pathways in vitro.","volume":"32","author":"Kaneshiro","year":"2014","journal-title":"J Bone Miner Metab"},{"key":"R40-20250503","doi-asserted-by":"crossref","first-page":"115044","DOI":"10.1016\/j.biopha.2023.115044","article-title":"The RAGE signaling in osteoporosis.","volume":"165","author":"Zhou","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"R41-20250503","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4103\/2230-8210.129105","article-title":"Type 1 diabetes and osteoporosis: a review of literature.","volume":"18","author":"Dhaon","year":"2014","journal-title":"Indian J Endocrinol Metab"},{"key":"R42-20250503","doi-asserted-by":"crossref","first-page":"1244372","DOI":"10.3389\/fcell.2023.1244372","article-title":"Bone angiocrine factors.","volume":"11","author":"Ribatti","year":"2023","journal-title":"Front Cell Dev Biol"},{"key":"R43-20250503","doi-asserted-by":"crossref","first-page":"12152","DOI":"10.1021\/jf504132x","article-title":"Quercetin inhibits advanced glycation end product formation by trapping methylglyoxal and glyoxal.","volume":"62","author":"Li","year":"2014","journal-title":"J Agric Food Chem"},{"key":"R44-20250503","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/biof.1699","article-title":"Luteolin as a modulator of skin aging and inflammation.","volume":"47","author":"Gendrisch","year":"2021","journal-title":"Biofactors"},{"key":"R45-20250503","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1007\/s10753-023-01849-8","article-title":"Kaempferol attenuates gouty arthritis by regulating the balance of Th17\/Treg cells and secretion of IL-17.","volume":"46","author":"Li","year":"2023","journal-title":"Inflammation"},{"key":"R46-20250503","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1124\/mol.104.010082","article-title":"Diosgenin induces hypoxia-inducible Factor-1 activation and angiogenesis through estrogen receptor-related phosphatidylinositol 3-kinase\/Akt and p38 mitogen-activated protein kinase pathways in osteoblasts.","volume":"68","author":"Yen","year":"2005","journal-title":"Mol Pharmacol"},{"key":"R47-20250503","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cbi.2017.04.026","article-title":"Enhanced therapeutic benefit of quercetin-loaded phytosome nanoparticles in ovariectomized rats.","volume":"271","author":"Abd El-Fattah","year":"2017","journal-title":"Chem Biol Interact"},{"key":"R48-20250503","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3389\/fmed.2017.00234","article-title":"Key triggers of osteoclast-related diseases and available strategies for targeted therapies: a review.","volume":"4","author":"Bi","year":"2017","journal-title":"Front Med (Lausanne)"},{"key":"R49-20250503","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/iub.1254","article-title":"The impact of bone marrow adipocytes on osteoblast and osteoclast differentiation.","volume":"66","author":"Muruganandan","year":"2014","journal-title":"IUBMB Life"},{"key":"R50-20250503","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/cdd.2015.168","article-title":"Fate decision of mesenchymal stem cells: adipocytes or osteoblasts?","volume":"23","author":"Chen","year":"2016","journal-title":"Cell Death Differ"},{"key":"R51-20250503","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.3390\/ijms21072277","article-title":"At the crossroads of the adipocyte and osteoclast differentiation programs: future therapeutic perspectives.","volume":"21","author":"Muruganandan","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R52-20250503","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2174\/1574888X12666171012141908","article-title":"PPAR-\u03b3 and Wnt regulate the differentiation of MSCs into adipocytes and osteoblasts respectively.","volume":"13","author":"Li","year":"2018","journal-title":"Curr Stem Cell Res Ther"},{"key":"R53-20250503","doi-asserted-by":"crossref","first-page":"181849","DOI":"10.1155\/2013\/181849","article-title":"Immunological reaction in TNF-\u03b1-mediated osteoclast formation and bone resorption in vitro and in vivo.","volume":"2013","author":"Kitaura","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"R54-20250503","first-page":"6605","article-title":"TNF-\u03b1 and RANKL promote osteoclastogenesis by upregulating RANK via the NF-\u03baB pathway.","volume":"17","author":"Luo","year":"2018","journal-title":"Mol Med Rep"},{"key":"R55-20250503","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1002\/jcb.25672","article-title":"Tumor necrosis factor alpha promotes osteoclast formation via PI3K\/Akt pathway-mediated blimp1 expression upregulation.","volume":"118","author":"Wu","year":"2017","journal-title":"J Cell Biochem"},{"key":"R56-20250503","doi-asserted-by":"crossref","first-page":"6448","DOI":"10.3390\/ijms21176448","article-title":"Quercetin as an agent for protecting the bone: a review of the current evidence.","volume":"21","author":"Wong","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R57-20250503","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0006-2952(02)01445-4","article-title":"Potent inhibitory effect of naturally occurring flavonoids quercetin and kaempferol on in vitro osteoclastic bone resorption.","volume":"65","author":"Wattel","year":"2003","journal-title":"Biochem Pharmacol"},{"key":"R58-20250503","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ejphar.2017.05.017","article-title":"Anhydroicaritin, a SREBPs inhibitor, inhibits RANKL-induced osteoclastic differentiation and improves diabetic osteoporosis in STZ-induced mice.","volume":"809","author":"Zheng","year":"2017","journal-title":"Eur J Pharmacol"},{"key":"R59-20250503","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1021\/acs.jafc.0c08085","article-title":"Dietary luteolin: a narrative review focusing on its pharmacokinetic properties and effects on glycolipid metabolism.","volume":"69","author":"Wang","year":"2021","journal-title":"J Agric Food Chem"},{"key":"R60-20250503","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.2174\/1389201021666201216150442","article-title":"Luteolin stimulates proliferation and inhibits late differentiation of primary rat calvarial osteoblast induced by high-dose dexamethasone via Sema3A\/NRP1\/Pleixin A1.","volume":"22","author":"Zheng","year":"2021","journal-title":"Curr Pharm Biotechnol"},{"key":"R61-20250503","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10616-010-9253-5","article-title":"Inhibitory effect of luteolin on osteoclast differentiation and function.","volume":"61","author":"Lee","year":"2009","journal-title":"Cytotechnology"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000039138","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:13:01Z","timestamp":1746317581000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000039138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,2]]},"references-count":61,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000039138","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,2]]}}}